Ozempic has a rival now: What is tirzepatide?
This new drug is a jab at Ozempic. Tirzepatide, a weekly injectable that rivals celebrity-favorite Wegovy, is one step closer to approval for weight loss by the Food and Drug Administration after its latest clinical trial showed promising results. Known under the brand name Mounjaro, the drug helped study participants shed nearly 16% of their … Read more
